Portfolio Building Block World Pharma and Biotech Index ETF
PBPH
1 hedge funds and large institutions have $896K invested in Portfolio Building Block World Pharma and Biotech Index ETF in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
88.78% more ownership
Funds ownership: 0% → 88.78% (+89%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$887K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $896K | +$887K | +35,513 | New |
|
PBPH Hedge Fund Activity: Q4 2025 in Review
1 of the 8,243 institutional investors tracked by Wall St. Rank reported a position in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) for Q4 2025, worth a combined $896K.
Buyers outnumbered sellers: 1 fund opened new PBPH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $887K.
- 1 institutional investor held Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) as of Q4 2025, up from 0 in Q3 2025.
- Funds reported $896K of Portfolio Building Block World Pharma and Biotech Index ETF stock for Q4 2025.
- 1 fund opened new Portfolio Building Block World Pharma and Biotech Index ETF positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest Portfolio Building Block World Pharma and Biotech Index ETF buyer in Q4 2025 was Citadel Advisors, an estimated $887K added.
Based on aggregated 13F filings for Q4 2025.